Watch for the company's response plan — typically a reverse stock split or capital raise to regain the $1.00 bid price within the 180-day cure period. Failure to announce a credible plan within weeks increases delisting risk. Monitor for a subsequent 8-K detailing the hearings panel decision or compliance steps.
Price Chart
Executive Summary
Silexion Therapeutics received a Nasdaq Staff letter on September 25, 2026, notifying the company that its ordinary shares have traded below the $1.00 minimum bid price for 30 consecutive business days, violating Listing Rule 5550(a)(2). The bid price deficiency will be considered by a Nasdaq hearings panel in its decision on whether to allow continued listing. The ordinary shares and warrants continue to trade normally for now, but the company faces potential delisting risk if it cannot regain compliance.
Key Facts
- Nasdaq Staff notified Silexion on September 25, 2026, that its ordinary shares closed below $1.00 for 30 consecutive business days
- The deficiency triggers consideration by a Nasdaq hearings panel for continued listing on the Nasdaq Capital Market
- Ordinary shares (SLXN) and warrants (SLXNW) continue trading normally with no immediate effect on listing
- No compliance plan or timeline (e.g., reverse split, capital raise) was disclosed in the filing
Financial Impact
Potential delisting would severely reduce institutional ownership and liquidity; no financial figures provided in the filing
Risk Factors
- Delisting from Nasdaq if the hearings panel denies continued listing or the company fails to regain compliance
- Severe liquidity contraction and loss of institutional investor access upon delisting
- Potential further share price decline as the market prices in delisting risk
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001178913-26-004609 |
| Document: 0001178913-26-004609-index-headers.html | 0001178913-26-004609 |
| Document: 0001178913-26-004609-index.html | 0001178913-26-004609 |
| Document: 0001178913-26-004609.txt | 0001178913-26-004609 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | DEFA14A | $0.1538 | awaiting T+20 | — | $0.1681 (−9.30%) |
Oct 5, 2026 21d ago | DEF 14A | $0.2628 | awaiting T+20 | — | $0.1681 (+36.04%) |
Sep 30, 2026 27d ago | 8-K | $0.2770 | awaiting T+20 | — | $0.1681 (−39.31%) |
Sep 30, 2026 27d ago | Press Release | $0.2773 | awaiting T+20 | — | $0.1681 (+39.38%) |
Sep 29, 2026 28d ago | 8-K | $0.3180 | awaiting T+20 | — | $0.1681 (+47.14%) |
Sep 29, 2026 28d ago | Press Release | $0.3184 | awaiting T+20 | — | $0.1681 (+47.20%) |
Sep 28, 2026 29d ago | 8-K | $0.2484 $0.1746 | ▼ −29.71% | ▼ −29.68% | $0.1681 (−32.33%) |
Sep 28, 2026 29d ago | Press Release | $0.2484 $0.1746 | ▼ −29.71% | ▼ −29.68% | $0.1681 (−32.33%) |
Sep 25, 2026 4w ago | 8-K | $0.2484 $0.1746 | ▲ +29.71% | ▲ +29.68% | $0.1681 (+32.33%) |
Aug 14, 2026 10w ago | 8-K | $0.4202 $0.3854 | ▲ +8.28% | ▲ +6.29% | $0.1681 (+60.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers